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OBJECTIVES The purpose of this study is to investigate the morphologic characteristics of the cardiac
interstitium in the hibernating human myocardium and evaluate whether active remodeling
is present and is an important determinant of functional recovery.
BACKGROUND Myocardial hibernation is associated with structural myocardial changes, which involve both
the cardiomyocytes and the cardiac interstitium.
METHODS We evaluated 15 patients with coronary disease with two-dimensional echocardiography and
thallium-201 (201Tl) tomography before coronary bypass surgery. During surgery, transmural
myocardial biopsies were performed guided by transesophageal echocardiography. Myocardial
biopsies were stained immunohistochemically to investigate fibroblast phenotype and exam-
ine evidence of active remodeling in the heart.
RESULTS Among the 29 biopsied segments included in the study, 24 showed evidence of systolic
dysfunction. The majority of dysfunctional segments (86.4%) were viable (201Tl uptake
60%). After revascularization, 12 dysfunctional segments recovered function as assessed
with an echocardiogram three months after bypass surgery. Interstitial fibroblasts expressing
the embryonal isoform of smooth muscle myosin heavy chain (SMemb) were noted in
dysfunctional segments, predominantly located in border areas adjacent to viable myocardial
tissue. Segments with recovery had higher SMemb expression (0.46  0.16% [n  12] vs.
0.10  0.02% [n  12]; p  0.05) and a higher ratio of alpha-smooth muscle actin to
collagen (0.14 0.026 [n 12] vs. 0.07 0.01 [n 12]; p 0.05) compared with segments
without recovery, indicating fibroblast activation and higher cellularity of the fibrotic areas. In
addition, interstitial deposition of the matricellular protein tenascin, a marker of active
remodeling, was higher in hibernating segments than in segments with persistent dysfunction
(p  0.05), suggesting an active continuous fibrotic process. Multiple logistic regression
demonstrated a significant independent association between SMemb expression and func-
tional recovery (p  0.01).
CONCLUSIONS Fibroblast activation and expression of SMemb and tenascin provide evidence of continuous
remodeling in the cardiac interstitium of the hibernating myocardium, an important predictor
of recovery of function after revascularization. (J Am Coll Cardiol 2002;39:1468–74)
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The concept of myocardial hibernation was introduced 15
years ago to describe impaired left ventricular (LV) function
that improves after revascularization (1,2). In the clinical
context, it may be the result of repetitive ischemic episodes
precipitated by increased demand in the setting of limited
flow reserve or chronically low resting myocardial blood
flow (3–5). Significant morphologic alterations involving
both the myocytes and the cardiac interstitial space have
been described in the hibernating myocardium (6–9). These
structural changes are considered to be important factors
responsible for the lack of immediate recovery of contractile
function after restoration of blood flow (9). Previous studies
have investigated the extensive structural alterations affect-
ing cardiomyocytes of hibernating myocardial areas, which
consist of depletion of contractile elements, glycogen accu-
mulation and depletion of sarcoplasmic reticulum (10,11).
Recently, the potential role of structural defects in the
myocardial extracellular matrix has been suggested. Elsasser
et al. (12) have found an enlarged extracellular space
containing cellular debris, macrophages, fibroblasts and
collagen fibrils, resulting in a significant degree of reparative
fibrosis.
Fibroblasts have a crucial role in regulating extracellular
matrix remodeling. In tissue fibrosis, fibroblastic cells dif-
ferentiate into myofibroblasts, expressing smooth muscle
cytoskeletal markers such as alpha-smooth muscle actin
(-SMAc). Activated myofibroblasts are dynamic regulators
of the fibrotic process through the synthesis of extracellular
matrix proteins and metalloproteinases. Recent studies in-
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dicated expression of the embryonal isoform of smooth
muscle myosin heavy chain (SMemb) by myofibroblasts in
reperfused myocardial infarcts and in pressure-overloaded
hearts (13). SMemb expression may serve as a marker of
fibroblast activation, identifying cells involved in matrix
remodeling. Furthermore, the matricellular protein tenascin
has been shown to be a marker of actively remodeling tissues
(14). Whether active remodeling in the interstitium is
present in the hibernating myocardium and is an important
determinant of recovery of function after revascularization
has not been previously investigated. Accordingly, the
present study evaluated the phenotypic characteristics of
interstitial fibroblasts as well as SMemb and tenascin
expression in the interstitium of hibernating human myo-
cardium to examine their relation to recovery of myocardial
function after revascularization.
METHODS
Patients scheduled for coronary artery bypass surgery who
had known ischemic heart disease and LV systolic dysfunc-
tion at rest in the distribution of 1 coronary arteries with
70% stenosis were enrolled in this study. A transthoracic
echocardiogram and thallium-201 single photon emission
tomography (201Tl SPECT) were performed two to seven
days before surgery. During surgery, transmural biopsies
were obtained from selected dysfunctional and normal
myocardial segments, guided by transesophageal echocardi-
ography (TEE) (15). Patients underwent transthoracic two-
dimensional echocardiography three months after surgery to
evaluate changes in regional function. The Institutional
Review Board of Baylor College of Medicine approved the
study protocol, and all patients signed informed consent
before enrollment.
Echocardiographic studies. Imaging was performed in the
standard parasternal and apical views with the patient in the
left lateral position (Sonos 2500, 2.5- or 3.5-MHz trans-
ducer, Hewlett Packard, Andover, Massachusetts). Re-
gional function was assessed according to the 16-segment
model of the American Society of Echocardiography and
graded from 1 to 5: 1  normal, 2  mild hypokinesia, 3 
severe hypokinesia, 4  akinesia and 5  dyskinesia (15).
Ejection fraction was quantified with the multiple diameter
method. The echocardiographic studies were interpreted
without knowledge of the histopathologic data. Recovery of
regional function was defined by improvement of 1
grades.
Rest-redistribution 201Tl. Rest and 4-h redistribution
201Tl SPECT scans were performed after intravenous ad-
ministration of 3 mCi of 201Tl before surgery as previously
described (16). A large field-of-view rotating gamma cam-
era with a high-resolution parallel-hole collimator was used.
Thirty-two frames were acquired over a 180° arc (45° left
posterior oblique to 45° left anterior oblique). The recon-
structed images were oriented in the standard short axis,
horizontal long axis and vertical long axis for interpretation
and quantification of 201Tl uptake by nuclear cardiologists
unaware of all other data. Computerized polar maps of the
three-dimensional myocardial radioactivity were generated.
A 16-segment model comparable to that for echocardiog-
raphy was used. Myocardial 201Tl activity was determined
with a region of interest 40 40 pixels (matrix 128 128).
The activity in each segment was normalized to the segment
with the highest uptake. A maximal uptake of 60% at rest
or redistribution was considered indicative of viability, as
previously demonstrated (16).
Transmural LV biopsies. Transmural myocardial biopsies
were obtained with a 20-mm 14-gauge Tru-cut biopsy
needle (Travenol Laboratories, Deerfield, Illinois) at the
time of surgery, before cardioplegia. Biopsy was directed by
TEE. Two segments were selected for each patient. For
patients who had segments with normal systolic function,
biopsies were acquired from one normal and one dysfunc-
tional segment. For all other patients, two dysfunctional
segments were biopsied. Segments with high likelihood for
viability were targeted by avoiding very thin walls (7 mm
thickness) and echodense myocardium, usually indicative of
a completed transmural infarction (17).
Immunohistochemistry and morphometry. Samples were
fixed in B*5 fixative (18) and embedded in paraffin. Sections
were stained with picrosirius red to identify areas of collagen
deposition. Serial sections were stained immunohistochemi-
cally with the following antibodies: -SMAc (Sigma, St.
Louis, Missouri) (19), SM1 and SM2 (markers for mature
smooth muscle cells), SMemb (Seikagaku America, Fal-
mouth, Massachusetts) (20), tenascin (Chemicon Interna-
tional, Temecula, California) and vinculin (Serotec, Ra-
leigh, North Carolina) (21). Staining was performed using a
peroxidase based technique with the Vectastain ELITE kit
(Vector Labs, Burlingame, California) and developed with
diaminobenzidine nickel (Vector), as previously described
(18,22). Slides were counterstained with eosin and exam-
ined in a Zeiss microscope (Oberkochen, Germany).
Quantitative analysis. For quantitative analysis, each sec-
tion was scanned at 200 magnification using a Leaf
Lumina digital camera (Leaf Systems, Southboro, Massa-
chusetts). The stained area for collagen, SMemb staining,
tenascin and -SMAc staining was quantitated using Zeiss
Image software and expressed as the percentage of the total
area of the section. In addition, the -SMAc:collagen ratio,
a marker of the cellularity of the cardiac interstitium, and
Abbreviations and Acronyms
-SMAc  alpha-smooth muscle actin
LV  left ventricular
SMemb  embryonal isoform of smooth muscle myosin
heavy chain
SPECT  single photon emission tomography
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TGF-  transforming growth factor-beta
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the tenascin:collagen ratio, an index of active remodeling,
were calculated for each myocardial segment.
Statistical analysis. Data are presented as mean  SEM.
In order to examine intrapatient correlation of the segment
data, we compared anterior and inferior or lateral segments
from the same patients and found no correlation in any of
the variables examined (collagen content: r  0.16, p 
0.63; SMemb staining: r  0.08, p  0.84; tenascin: r 
0.14, p  0.71; -SMAc staining: r  0.34, p  0.33;
change in wall motion score after revacularization: r 0.24,
p  0.79). Thus, segment-by-segment analysis was per-
formed as previously described (23). Unpaired t test was
used to compare the pathologic variables between dysfunc-
tional and nondysfunctional segments and segments with
and without recovery of function after revascularization.
Paired t test was used to compare the preoperative and
postoperative ejection fraction. Collagen staining and
-SMAc expression were correlated with wall motion score
using the Spearman coefficient. The same method was used
for correlation studies between SMemb expression and the
-SMAc:collagen ratio or the tenascin:collagen ratio. Chi
square analysis was used to examine the relation between
SMemb or tenascin expression in the myocardium and
recovery of function after revascularization. In addition,
forward stepwise multiple logistic regression (Wald) was
used to correlate recovery of function with 201Tl uptake and
the histomorphometric variables. GraphPad Instat version
(GraphPad Software, San Diego, California) 3.1 and SSPS
7.0 (SPSS Inc., Chicago, Illinois) software were used for the
statistical analysis. Significance was set at p  0.05.
RESULTS
Patient population. Fifteen patients were enrolled in the
study. There were 13 men and 2 women with a mean age of
62 years (range: 50 to 73 years). The mean LV ejection
fraction was 29.4  2%. Ten patients (67%) had hyperten-
sion, 9 (60%) were diabetic, 10 (67%) had angina pectoris
and 8 (56%) had congestive heart failure. Thirteen patients
underwent rest-redistribution thallium SPECT. Twenty-
nine myocardial segments were biopsied and used for the
study. One additional segment was excluded due to inade-
quate sampling. The average myocardial area of the biopsied
samples used for quantitative analysis was 3.2  0.45 mm2
(n 29). Five segments showed normal wall motion, 4 were
mildly hypokinetic, 14 severely hypokinetic and 6 were
akinetic. Mean myocardial 201Tl uptake was 69.5  2.4%.
The vast majority of biopsied segments were viable (19 of 22
[86.4%] dysfunctional segments had an uptake 60%, and
all except one had an uptake of 50%). All patients
underwent complete revascularization without complica-
tions. Of the 24 dysfunctional segments, 12 segments
recovered function after revascularization. The mean LV
ejection fraction three months after revascularization was
38.6  3.3% (p  0.001, n  15, compared with ejection
fraction before revascularization).
Relation of collagen deposition to myocardial function.
Cardiomyocytes in dysfunctional myocardial segments
demonstrated significant structural abnormalities. Segments
with persistent dysfunction after revascularization showed
more extensive alterations, including sarcomere loss and
disorganization of the contractile material (Fig. 1). Percent
collagen content of the biopsies ranged between 6.32 and
72.4 (mean: 22.6  2.99). A significant correlation was
found between collagen percent staining and regional wall
motion score (r  0.53, n  29; p  0.01). Collagen
staining was significantly higher in dysfunctional segments
(n  24) when compared with segments showing normal
(n  5) systolic function (24.99  3.42 vs. 11.12  1.11;
p  0.001).
Phenotypic characteristics of myofibroblasts in the myo-
cardial interstitial space in dysfunctional segments versus
normal. Immunohistochemical staining with antibodies to
-SMAc and the smooth muscle myosin isoforms SM1,
SM2 and SMemb was used to identify myofibroblasts and
smooth muscle cells in the myocardium. The -SMAc
immunoreactivity was localized in the vascular media and in
pericytes and myofibroblasts, predominantly located in areas
of fibrosis. Medial smooth muscle cells of myocardial
arterioles expressed -SMAc, SM1 and SM2 but not
SMemb (Fig. 2). Interstitial cells expressing SMemb were
noted in dysfunctional myocardial segments, predominantly
located in border areas between fibrotic regions and areas
with relatively preserved myocyte architecture (Fig. 3).
These cells were negative for SM1 and SM2, both markers
of mature smooth muscle cells. Percent staining with
-SMAc correlated well with collagen expression (r 0.64,
n  29; p  0.0002), reflecting the localization of myofi-
broblasts in areas of fibrosis. A trend towards higher
-SMAc expression was noted in dysfunctional myocardial
segments compared with those with normal systolic func-
Figure 1. Structural alterations of the myocytes and the cardiac intersti-
tium in dysfunctional myocardial segments. (A) Segment with preserved
function showing relatively few morphologic abnormalities. (B) Segment
with reversible dysfunction demonstrating a widened interstitial space
(arrows), with a relatively high cellular content, and myocyte degeneration
with significant loss of contractile material (arrowheads). (C) Segments
with persistent dysfunction after revascularization show more extensive
pathologic changes, severe sarcomeric loss and significant extracellular
matrix accumulation in the cardiac interstitium. All slides were stained with
hematoxylin-eosin (400).
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tion (dysfunctional: 2.49  0.5% [n  24] vs. normal:
1.25  0.47% [n  5], p  0.092).
Myofibroblasts also demonstrated expression of vinculin,
a protein found in focal adhesion plaques, involved in cell
attachment with extracellular matrix (Figs. 4C and 5C).
Vinculin, also an important component of the cytoskeleton
of myocytes, was localized in the sarcolemma and the
intercalated discs. Cardiomyocytes with disorganized cyto-
plasmic expression of vinculin were found in dysfunctional
myocardial segments (Fig. 5C).
High cellularity of the cardiac interstitium and expres-
sion of SMemb is associated with recovery of function
after revascularization. Recovery of function occurred in
12 of 24 dysfunctional myocardial segments. Thallium
uptake and quantitative morphometric parameters in seg-
ments with and without recovery are shown in Table 1.
Thallium uptake was preserved in the majority of segments
and was not significantly different in segments with and
without recovery of function after revascularization (Table
1). In addition, percent collagen staining and percent
-SMAc staining were not significantly different in the two
groups (collagen staining: recovery 20.2  2.1% vs. no
recovery: 29.8  6.4%, p  0.18 and -SMAc staining:
recovery of function, 1.87  0.29% vs. no recovery 2.94 
0.87%, p  0.26). However, segments with improved
function demonstrated less advanced fibrotic changes, char-
acterized by an interstitial space with a higher cellular
content in relation to collagen deposition. This was reflected
by the -SMA:collagen ratio, which was significantly
higher in segments with recovery (Table 1). Furthermore,
segments with recovery showed significantly higher expres-
sion of SMemb when compared with segments demonstrat-
ing persistent dysfunction (Table 1). Segments with percent
Figure 2. Smooth muscle cells and myofibroblasts in the dysfunctional
human myocardium. Immunostaining of serial sections for SM1 (A), SM2
(B), markers of mature smooth muscle cells, the embryonic isoform of
smooth muscle myosin heavy chain (SMemb) (C), and alpha-smooth
muscle actin (-SMAc) (D). Note that the myocardial arteriole (arrows)
expresses SM1 (A), SM2 (B) and -SMAc (D) but not SMemb (C).
Expression of SMemb is noted in interstitial myofibroblasts (C), which are
also positive for -SMAc. Counterstained with eosin (100).
Figure 3. The embryonic isoform of smooth muscle myosin heavy chain
(SMemb) positive cells are predominantly localized in border zone areas
adjacent to viable myocytes. Serial sections from a hibernating myocardial
segment were stained for SM1 (A), SM2 (B), SMemb (C) and collagen
(D). Arteriolar smooth muscle cells (arrows) express SM1 and SM2 but
not SMemb. In contrast, the interstitial SMemb positive cells (C) are
negative for SM1 and SM2 and are predominantly located in border areas
adjacent to viable myocytes. Areas with extensive collagen deposition show
lower SMemb expression (100). (E) High magnification image of an area
from a hibernating myocardial segment stained for SMemb. Note that
SMemb expression is localized in spindle-shaped interstitial cells (1,000).
Figure 4. Immunohistochemistry for tenascin (A), alpha-smooth muscle
actin (-SMAc) (B) and vinculin (C) in the dysfunctional human myo-
cardium from a segment with recovery of function after revascularization.
Marked deposition of tenascin is noted in the cardiac interstitial space,
suggesting an active continuous remodeling process. Interstitial myofibro-
blasts demonstrate expression of the focal adhesion protein vinculin (C), a
factor promoting their attachment to the matrix. Note that vinculin
immunoreactivity is also noted in the sarcolemma and the intercalated discs
(200). Counterstained with eosin.
Figure 5. Immunohistochemistry for tenascin (A), alpha-smooth muscle
actin (-SMAc) (B) and vinculin (C) in the dysfunctional human myo-
cardium from a segment with persistent dysfunction after revascularization.
Tenascin immunoreactivity is present in the cardiac interstitium; however,
its expression is low in comparison with the extent of fibrosis. In addition,
vinculin-positive, -SMAc expressing myofibroblasts are found in the
fibrotic area (arrow). Note the presence of myocytes with extensive
degenerative changes, demonstrating disorganized cytoplasmic expression
of vinculin (arrowheads). Counterstained with eosin (200).
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SMemb staining 0.15% had significantly higher likeli-
hood of recovery compared with those with 0.15% (p 
0.012).
Evidence for active remodeling in the cardiac intersti-
tium from hibernating segments: expression of tenascin.
To evaluate whether active matrix remodeling is present in
the dysfunctional human myocardium, the expression of the
matricellular protein tenascin was quantitated in the biop-
sied segments. There was low expression of tenascin in
segments with normal function. In contrast, dysfunctional
segments showed significantly higher expression of tenascin
(dysfunctional: 1.29  0.28% [n  24] vs. normal: 0.32 
0.23% [n  5]; p  0.016), predominantly located in the
cardiac interstitial space, indicating an active remodeling
process (Fig. 4A). Tenascin staining was localized in the
extracellular matrix, with minimal cytoplasmic expression by
fibroblasts or smooth muscle cells. Importantly, segments
with recovery of function demonstrated extensive tenascin
staining in the interstitial space (Fig. 4A), whereas, in
segments with persistent dysfunction, tenascin immunore-
activity was more limited in comparison with the extent of
fibrosis (Fig. 5A). Segments with recovery of function
showed a higher tenascin:collagen ratio than segments with
persistent dysfunction (Table 1), indicating a more active
remodeling process. Segments with a tenascin:collagen ratio
0.055 had a significantly higher likelihood of recovery
than segments with a ratio 0.055 (odds ratio  15.4, p 
0.027).
Histologic indicators of active remodeling are associated
with recovery of function after revascularization. Using
multiple logistic regression we found that percent SMemb
staining (p  0.0098) and the -SMAc:collagen ratio (p 
0.0215) were significantly associated with recovery of func-
tion after revascularization. We identified a weaker associ-
ation of the functional outcome with the tenascin:collagen
ratio (p  0.093), which did not attain statistical signifi-
cance. Thallium uptake, which exceeded 60% in the major-
ity of segments, was not an independent predictor of
recovery (p  0.195). Significant correlations were found
between the two ratios and SMemb expression (-SMAc:
collagen ratio with SMemb r  0.483, p  0.05; tenascin:
collagen ratio with SMemb r  0.634, p  0.01), reflecting
the fact that all three morphometric variables represent
indicators of interstitial space activity.
DISCUSSION
Chronic ischemic LV dysfunction is associated with profound
structural alterations affecting both the cardiomyocytes and the
interstitial space (24,25). There is a well-described loss of
contractile material within the cardiomyocytes accompanied
by a significant increase in extracellular matrix (26). Elsasser
et al. (12) described the accumulation of collagen fibrils and
fibronectin in the widened interstitial space, suggesting that
the combination of cellular degeneration and fibrosis may
determine the degree and speed of recovery of dysfunctional
myocardial segments after bypass operation. They postu-
lated that in the hibernating myocardium a self-
perpetuating vicious cycle of tissue alterations may lead to
progressive fibrosis and continuous cellular degeneration.
The present study examined the pathologic features of
the cardiac interstitial space in patients with regional isch-
emic dysfunction. By excluding dysfunctional myocardial
segments with an end-diastolic thickness 7 mm, we
ensured that our study examines segments with viable
myocardium and a substantial chance of recovery after
revascularization (17). The viability of the biopsied myocar-
dial segments was supported by 201Tl SPECT, showing a
201Tl uptake 60% in 86.4% (19 of 22) of the dysfunctional
segments. The present study underlines the importance of
the morphologic characteristics of the cardiac interstitium in
determining recovery of function after revascularization. We
report, for the first time, deposition of tenascin, a matricel-
lular protein transiently expressed in actively remodeling
tissues, in the interstitium of hibernating segments. In
addition, we describe infiltration of the hibernating myo-
cardium with phenotypically modulated myofibroblasts pro-
ducing SMemb, a marker of activation. Our findings sup-
port the concept that ischemic myocardial dysfunction may
be associated with a continuous, progressive fibrotic process,
where activated interstitial fibroblasts may have a prominent
role through the production of extracellular matrix compo-
nents. The presence of active remodeling in the cardiac
interstitium of the hibernating myocardium appears to be an
important process in determining recovery of function after
revascularization in segments with evidence of myocardial
viability by thallium uptake and preserved myocardial thick-
ness.
Fibroblasts in hibernating myocardium: -SMAc expres-
sion and significance. Interstitial fibroblasts are responsi-
ble for myocardial collagen metabolism and may mediate
systolic and diastolic ventricular dysfunction through the
production of extracellular matrix proteins, matrix metal-
loptoteinases and growth factors (27–29). Fibroblast differ-
entiation and activation is a prominent characteristic of
wound healing and is associated with synthesis of -SMAc
and expression of a myofibroblast-like phenotype. Myofi-
broblasts are the main collagen-producing cells in myocar-
dial infarcts (30) and may serve as a versatile cell population,
assuming different phenotypes depending on the physiolog-
ical needs (21). In the present study, dysfunctional myocar-
Table 1. Comparison of 201Tl Uptake and the Morphometric
Variables in Segments With and Without Recovery of Function
After Revascularization
Variables Recovery No Recovery p Value
201Tl uptake (%) 73.1  2.7% 66.3  4.3% 0.24
Collagen (%) 20.2  2.1% 29.8  6.4% 0.18
-SMAc: collagen ratio 0.14  0.026 0.07  0.01  0.05
Tenascin: collagen ratio 0.074  0.018 0.028  0.01  0.05
SMemb (%) 0.46  0.16% 0.10  0.02%  0.05
-SMAc  alpha-smooth muscle actin; SMemb  embryonal isoform of smooth
muscle myosin heavy chain; 201Tl  thallium-201.
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dial segments showed significant numbers of myofibroblasts
expressing -SMAc. Segments demonstrating recovery of
function after revascularization had a higher -SMAc:
collagen ratio when compared with segments with persistent
dysfunction (Table 1). This reflects a more cellular intersti-
tial space in hibernating myocardial tissue. In contrast,
segments without recovery showed extensive extracellular
matrix deposition associated with a relatively low expression
of -SMAc. This finding may be explained by the limited
life span of myofibroblasts in fibrotic tissues; during wound
healing myofibroblasts disappear by means of apoptosis, and
granulation tissue gradually transforms into scar tissue (31).
Thus, segments without recovery of function may represent
the late stages of a continuous process of interstitial fibrosis,
associated with a less cellular environment.
Fibroblasts in hibernating myocardium: SMemb expres-
sion and significance. The SMemb is a nonmuscle myosin
heavy chain isoform, predominantly present in the fetal
aorta, whose expression is upregulated in immature dedif-
ferentiated intimal cells (32). Recently, SMemb induction
was noted in activated cardiac myofibroblasts from pressure
overloaded rat hearts (13) and in the border zone of healing
myocardial infarcts (21). Myofibroblast differentiation and
SMemb expression can be induced by stimulation with
transforming growth factor-beta (TGF-) (13), a cytokine
known to be upregulated in the hibernating myocardium
(33). To date, whether SMemb is expressed in hibernating
myocardium has not been previously investigated. In the
present study, a subpopulation of myofibroblasts expressed
SMemb and was predominantly located in border areas
between fibrotic regions and areas with preserved myocyte
architecture (Figs. 2 and 3). The SMemb expression was
significantly higher in segments that exhibited recovery of
function after revascularization (Table 1). This may again
reflect an earlier stage of the fibrotic process associated with
fibroblast activation. In addition, in a multiple logistic
regression model, SMemb expression was significantly and
independently associated with the functional outcome after
revascularization. This finding underlines the association
between an active interstitial space and functional recovery.
Tenascin deposition in hibernating myocardium.
Tenascin is a multifunctional extracellular matrix glycopro-
tein that is exquisitely regulated during embryonic develop-
ment and in adult tissue remodeling (14). Tenascin belongs
to a class of matrix proteins, termed matricellular proteins,
that function as modulators of cell-matrix interactions (34).
Matricellular proteins may regulate tissue remodeling
through promotion of the “de-adhesive state,” an interme-
diate state of cellular adhesiveness, which may facilitate
repair and adaptation (35). Tenascin is not normally ex-
pressed in the adult heart but reappears in a variety of
pathologic conditions (36) such as dilated cardiomyopathy
and myocardial infarction (37,38). During the acute phase
of myocardial infarction, tenascin is synthesized and depos-
ited in the border zone, possibly facilitating tissue reorga-
nization (37); however, its expression almost disappears two
weeks after a nonreperfused myocardial infarction. Our
study demonstrated persistent interstitial deposition of te-
nascin in the dysfunctional human myocardium, suggesting
an active continuous process of matrix remodeling. The
tenascin:collagen ratio, a marker of tenascin deposition in
the cardiac interstitium, was significantly higher in seg-
ments with recovery (Table 1), suggesting the presence of an
active remodeling process in hibernating segments. These
findings support the concept that ischemic cardiomyopathy
represents a dynamic process associated with continuous
deposition of extracellular matrix, leading to a state of
extensive fibrosis, potentially associated with a lower chance
of functional recovery.
Potential implications of the findings for the pathophys-
iology of myocardial hibernation. In the absence of an
acute coronary event, ischemic contractile dysfunction may
be a chronically progressive condition. We propose the
following pathophysiologic process that involves the inter-
stitium in hibernating myocardium based on previous data
and observations from the present study. In the early stages,
ischemia-induced signals, such as TGF- synthesis and
release, may lead to fibroblast accumulation in the intersti-
tial space. Accumulating fibroblasts may undergo pheno-
typic changes, such as the expression of -SMAc and
SMemb. Interstitial expression of the matricellular protein
tenascin may have a role in modulating cellular adhesion
and cytokinesis, promoting matrix remodeling. At a later
stage, and despite the presence of myocardial viability
(preserved thickness and 201Tl uptake), the cardiac intersti-
tium becomes a less cellular environment, dominated by
extracellular matrix accumulation and showing lower levels
of inflammatory activity. This stage is associated with a
lower likelihood of functional recovery, further supporting
the need for early revascularization in patients with sus-
pected myocardial hibernation.
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